You are about to leave Peijia Medical's official Chinese website.
You have just clicked on a link to another website. After clicking Continue, you may be taken to a website run by a third party. We are not responsible for the review and control of content outside Peijia Medical's official Chinese website, nor do we assume any responsibility for business transactions or matters conducted outside Peijia Medical's official Chinese website. The use of other websites is subject to the terms of use and privacy policies of those websites. Certain products or information found on other websites may not be approved for your region or country.
Cancel
Continue

A Global Service Provider of Innovative Medical Products and Solutions

Focusing on the innovation, R&D and production of high-end medical devices for structural heart and cerebrovascular disease intervention, Peijia Medical covers the entire product pipeline for aortic, mitral and tricuspid valve replacements and related surgical instruments and accessories, as well as diseases related to hemorrhage, ischemia and access in the field of cerebrovascular intervention. It has built a domestic portfolio of products and solutions in the field of  structural heart and cerebrovascular disease.

9996.HK
Stock Code
12Years
Duration of Existence
23
Launched Products
20+
Pre - Clinical
400+
Global Patents (Applied for)
600+
Hospital(SHD)
2300+
Hospital(NVU)
More
Solutions

Adhering to the corporate vision of "Devoted to Heart, Reverence for Life", Peijia Medical strives to be a respected global high-tech medical enterprise. Staying true to our original values, we are fully focused on serving patients by providing safe, effective and affordable products and solutions. With continuous innovation, we aim to alleviate the suffering of patients and improve their quality of life. 

Valvular Heart Disease
Stroke
Products

Cardiovascular and cerebrovascular diseases are one of the main causes of death all year round. Peijia Medical has long been committed to developing interventional therapies for structural heart disease and cerebrovascular diseases—a field in urgent need of breakthroughs. Powered by independent innovation and the world’s latest technological developments, the Company focuses on research hotspots at the global frontier of medicine, helping patients around the world to live healthier and better lives.

More

Company News

More
Professional Education
More
Innovation Ecosystem
More
Top